Replay available

Abaxx Technologies Inc (ABXXF) Q1 2025 Earnings Call

Abaxx Technologies Inc (OTC: ABXXF) Q1 2025 earnings conference call, held 2025-04-10. Replay captured from the company's public earnings webcast.

Thu, April 10, 2025 at 10:00 AMendedReplay
Abaxx Technologies Inc (ABXXF) Q1 2025 Earnings Call

Hosted by

Featured presenters

Joe Rea

Chief Commercial Officer

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Abaxx Technologies Inc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.027 -- 00:00:05.775 Thanks. Well, good morning, everyone, and good evening for those of you joining us from 00:00:05.775 -- 00:00:07.218 Singapore. 00:00:07.218 -- 00:00:13.008 Welcome to the APEX Technologies and APEX Exchange Q1 2025 Corporate Update Call. 00:00:13.008 -- 00:00:18.457 During today's call, I'll reference disclosures from Tuesday's Q1 2025 Quarterly Business 00:00:18.457 -- 00:00:23.586 and Corporate Update and last week's filing of our 2024 Audited Annual Financial Statements 00:00:23.586 -- 00:00:26.693 and related filings on CDAR+. 00:00:26.693 -- 00:00:30.681 By reference to these press releases and disclosures, I also want to draw your attention 00:00:30.681 -- 00:00:34.429 to some of the specific cautionary statements and notices that accompany each of those 00:00:34.429 -- 00:00:38.817 releases, respectively, and to start off this call today by referring to our caution 00:00:38.817 -- 00:00:42.966 on forward-looking statements and the regular risk disclosures of our quarterly and annual 00:00:42.966 -- 00:00:44.589 filings. 00:00:44.589 -- 00:00:49.074 Please see our disclaimer on forward-looking statements in the slide attached. 00:00:49.103 -- 00:00:53.349 In addition, given the highly regulated nature of our products and operations and the 00:00:53.349 -- 00:00:58.317 early growth stage of our ramp-up and listing of new products as the year progresses, 00:00:58.317 -- 00:01:03.084 it's also important to reiterate the cautionary nature of our forward-looking statements 00:01:03.084 -- 00:01:08.071 with respect to products that are still subject to ongoing regulatory work and review. 00:01:08.071 -- 00:01:10.788 I will endeavor to point out these cautions as we go. 00:01:10.788 -- 00:01:15.435 But as of today, our Abbott Singa...